Dr. James Douglas Lawson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 2704 Henry St, Greensboro, NC 27405 Phone: 336-621-3777 Fax: 336-621-8374 |
Peter Van Trigt Iii, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 301 E Wendover Ave, Suite 411, Greensboro, NC 27401 Phone: 336-832-3200 Fax: 336-832-3201 |
Steven C Hendrickson, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 301 E Wendover Ave, Suite 411, Greensboro, NC 27401 Phone: 336-832-3200 Fax: 336-832-3201 |
Bailey Christine Stehler, PA-C Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 301 E Wendover Ave Ste 411, Greensboro, NC 27401 Phone: 336-832-3200 |
Dr. Harrell Lightfoot, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 301 E Wendover Ave Ste 411, Greensboro, NC 27401 Phone: 336-832-3200 |
Edward B Gerhardt, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 301 E Wendover Ave, Suite 411, Greensboro, NC 27401 Phone: 336-832-3200 Fax: 336-832-3201 |
Donald P Burney, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 301 E Wendover Ave, Suite 411, Greensboro, NC 27401 Phone: 336-832-3200 Fax: 336-832-3201 |
News Archive
AmerisourceBergen Corporation today reported that in its fiscal year 2010 fourth quarter ended September 30, 2010, diluted earnings per share increased 13.6 percent to $0.50, and revenue increased 5.3 percent to a record $19.7 billion.
Adolescent obesity is a major public health problem that impacts one out of every three children, resulting in 4-5 million overweight youth in the United States. In a study published in the December 2009 issue of the Journal of the American Dietetic Association, researchers evaluated differences in weight control behaviors, including dietary intake and physical activity, comparing overweight adolescents who lost weight and those who did not in order to better understand which strategies could be most effective.
Biota Holdings Limited today announced that Daiichi Sankyo has received approval to manufacture and market InavirĀ® in Japan. InavirĀ® is Daiichi Sankyo's brand of laninamivir octanoate and also previously known as CS-8958. The approved indication is for the treatment of influenza in adults and children.
Synergy Pharmaceuticals, Inc. a developer of new drugs to treat gastrointestinal disorders (GI) and diseases, announced today that it has been awarded a $244,479 grant under the Qualifying Therapeutic Discovery Project (QTDP) program to aid the Company in its development of plecanatide currently in clinical development to treat gastrointestinal disorders.
› Verified 3 days ago